
Sign up to save your podcasts
Or


Dr. David Fajgenbaum, Physician-Scientist at the University of Pennsylvania and Co-Founder and President of Every Cure, studies how existing medicines can be repurposed to treat diseases they were not originally designed for.
What if the cure for a deadly condition is already sitting on a pharmacy shelf, just waiting to be matched to the right disease? A growing field of research focuses on drug repurposing, finding new uses for medications that are already approved and available.
With the help of artificial intelligence, researchers can now scan billions of possible drug-disease combinations, dramatically accelerating the search for life-saving treatments.
By Newswise Inc.5
88 ratings
Dr. David Fajgenbaum, Physician-Scientist at the University of Pennsylvania and Co-Founder and President of Every Cure, studies how existing medicines can be repurposed to treat diseases they were not originally designed for.
What if the cure for a deadly condition is already sitting on a pharmacy shelf, just waiting to be matched to the right disease? A growing field of research focuses on drug repurposing, finding new uses for medications that are already approved and available.
With the help of artificial intelligence, researchers can now scan billions of possible drug-disease combinations, dramatically accelerating the search for life-saving treatments.

625 Listeners

139 Listeners

523 Listeners

1,276 Listeners

369 Listeners

113 Listeners

76 Listeners

33 Listeners

160 Listeners

10 Listeners

7 Listeners

64 Listeners

9 Listeners